New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.

The use of general anesthetics show promise in treating depression and mood disorders, based on the results of a novel study.

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Some people will experience only one depressive episode in their life, while others may have depression throughout their ...

The potential of ketamine has opened the door to an exciting new era in depression treatment. Researchers are actively investigating the development of other drugs targeting the glutamate system ...

Glutamate is what many of the neurons in your ... Chadi Abdallah: When people are stressed for a long time or when they suffer from depression for a while, they start losing these connections ...

Depression is considered treatment-resistant ... Ketamine works by blocking a non-monoamine neurotransmitter, glutamate, which influences the activity of all other neurotransmitters.

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...

There is no single known cause of depression. Rather, it likely results from a combination of genetic, biologic, environmental, and psychological factors. Major negative experiences—trauma, loss ...

Now a sub-study shows that there is also ... Sleeping for 2: Insomnia Therapy Reduces Postpartum Depression, Study Shows Oct. 31, 2024 — CBT for insomnia significantly reduces postpartum ...